nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—Urinary retention—Valrubicin—urinary bladder cancer	0.0397	0.0457	CcSEcCtD
Benzatropine—Dysuria—Valrubicin—urinary bladder cancer	0.0337	0.0388	CcSEcCtD
Benzatropine—Ileus—Thiotepa—urinary bladder cancer	0.0281	0.0324	CcSEcCtD
Benzatropine—Memory impairment—Thiotepa—urinary bladder cancer	0.0254	0.0292	CcSEcCtD
Benzatropine—Appetite absent—Methotrexate—urinary bladder cancer	0.0172	0.0198	CcSEcCtD
Benzatropine—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0169	0.0194	CcSEcCtD
Benzatropine—Vision blurred—Mitomycin—urinary bladder cancer	0.0163	0.0188	CcSEcCtD
Benzatropine—Body temperature increased—Valrubicin—urinary bladder cancer	0.0162	0.0187	CcSEcCtD
Benzatropine—Benzphetamine—POR—urinary bladder cancer	0.0151	1	CrCbGaD
Benzatropine—Body temperature increased—Carboplatin—urinary bladder cancer	0.015	0.0173	CcSEcCtD
Benzatropine—Confusional state—Mitomycin—urinary bladder cancer	0.0143	0.0164	CcSEcCtD
Benzatropine—Urinary retention—Thiotepa—urinary bladder cancer	0.0138	0.0158	CcSEcCtD
Benzatropine—Disorientation—Fluorouracil—urinary bladder cancer	0.0134	0.0154	CcSEcCtD
Benzatropine—Vomiting—Valrubicin—urinary bladder cancer	0.013	0.015	CcSEcCtD
Benzatropine—Rash—Valrubicin—urinary bladder cancer	0.0129	0.0149	CcSEcCtD
Benzatropine—Dermatitis—Valrubicin—urinary bladder cancer	0.0129	0.0149	CcSEcCtD
Benzatropine—Cerebrovascular accident—Gemcitabine—urinary bladder cancer	0.0124	0.0143	CcSEcCtD
Benzatropine—Decreased appetite—Mitomycin—urinary bladder cancer	0.0123	0.0141	CcSEcCtD
Benzatropine—Nausea—Valrubicin—urinary bladder cancer	0.0122	0.014	CcSEcCtD
Benzatropine—Dysuria—Thiotepa—urinary bladder cancer	0.0117	0.0134	CcSEcCtD
Benzatropine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0116	0.0134	CcSEcCtD
Benzatropine—Cerebrovascular accident—Cisplatin—urinary bladder cancer	0.0116	0.0133	CcSEcCtD
Benzatropine—Ileus—Epirubicin—urinary bladder cancer	0.0113	0.013	CcSEcCtD
Benzatropine—Body temperature increased—Mitomycin—urinary bladder cancer	0.0112	0.0129	CcSEcCtD
Benzatropine—Ileus—Doxorubicin—urinary bladder cancer	0.0105	0.0121	CcSEcCtD
Benzatropine—Dysphagia—Fluorouracil—urinary bladder cancer	0.0103	0.0119	CcSEcCtD
Benzatropine—Vomiting—Mitomycin—urinary bladder cancer	0.00899	0.0103	CcSEcCtD
Benzatropine—Dysphagia—Etoposide—urinary bladder cancer	0.00898	0.0103	CcSEcCtD
Benzatropine—Rash—Mitomycin—urinary bladder cancer	0.00891	0.0102	CcSEcCtD
Benzatropine—Dermatitis—Mitomycin—urinary bladder cancer	0.0089	0.0102	CcSEcCtD
Benzatropine—Tension—Thiotepa—urinary bladder cancer	0.00855	0.00983	CcSEcCtD
Benzatropine—Nervousness—Thiotepa—urinary bladder cancer	0.00846	0.00973	CcSEcCtD
Benzatropine—Nausea—Mitomycin—urinary bladder cancer	0.0084	0.00966	CcSEcCtD
Benzatropine—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00823	0.00947	CcSEcCtD
Benzatropine—Vision blurred—Thiotepa—urinary bladder cancer	0.00821	0.00944	CcSEcCtD
Benzatropine—CYP2C19—urine—urinary bladder cancer	0.00757	0.228	CbGeAlD
Benzatropine—Confusional state—Thiotepa—urinary bladder cancer	0.00717	0.00824	CcSEcCtD
Benzatropine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00715	0.00822	CcSEcCtD
Benzatropine—Tachycardia—Thiotepa—urinary bladder cancer	0.00694	0.00798	CcSEcCtD
Benzatropine—Vision blurred—Fluorouracil—urinary bladder cancer	0.00679	0.00781	CcSEcCtD
Benzatropine—Vision blurred—Cisplatin—urinary bladder cancer	0.00644	0.0074	CcSEcCtD
Benzatropine—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.00635	0.0073	CcSEcCtD
Benzatropine—Decreased appetite—Thiotepa—urinary bladder cancer	0.00618	0.00711	CcSEcCtD
Benzatropine—Constipation—Thiotepa—urinary bladder cancer	0.00608	0.00699	CcSEcCtD
Benzatropine—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.00594	0.00683	CcSEcCtD
Benzatropine—Confusional state—Fluorouracil—urinary bladder cancer	0.00593	0.00682	CcSEcCtD
Benzatropine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00586	0.00674	CcSEcCtD
Benzatropine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00574	0.0066	CcSEcCtD
Benzatropine—Body temperature increased—Thiotepa—urinary bladder cancer	0.00562	0.00646	CcSEcCtD
Benzatropine—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.0055	0.00632	CcSEcCtD
Benzatropine—Tachycardia—Cisplatin—urinary bladder cancer	0.00544	0.00626	CcSEcCtD
Benzatropine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00524	0.00602	CcSEcCtD
Benzatropine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.0052	0.00598	CcSEcCtD
Benzatropine—Confusional state—Etoposide—urinary bladder cancer	0.00515	0.00592	CcSEcCtD
Benzatropine—Constipation—Gemcitabine—urinary bladder cancer	0.00511	0.00588	CcSEcCtD
Benzatropine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00511	0.00588	CcSEcCtD
Benzatropine—Dysphagia—Epirubicin—urinary bladder cancer	0.00503	0.00579	CcSEcCtD
Benzatropine—Dysuria—Methotrexate—urinary bladder cancer	0.00503	0.00578	CcSEcCtD
Benzatropine—Tachycardia—Etoposide—urinary bladder cancer	0.00498	0.00573	CcSEcCtD
Benzatropine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00493	0.00567	CcSEcCtD
Benzatropine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00484	0.00557	CcSEcCtD
Benzatropine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00484	0.00557	CcSEcCtD
Benzatropine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00473	0.00544	CcSEcCtD
Benzatropine—Dysuria—Epirubicin—urinary bladder cancer	0.00471	0.00541	CcSEcCtD
Benzatropine—Dysphagia—Doxorubicin—urinary bladder cancer	0.00466	0.00536	CcSEcCtD
Benzatropine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00465	0.00535	CcSEcCtD
Benzatropine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00459	0.00528	CcSEcCtD
Benzatropine—Vomiting—Thiotepa—urinary bladder cancer	0.00452	0.0052	CcSEcCtD
Benzatropine—Rash—Thiotepa—urinary bladder cancer	0.00448	0.00515	CcSEcCtD
Benzatropine—Dermatitis—Thiotepa—urinary bladder cancer	0.00448	0.00515	CcSEcCtD
Benzatropine—Decreased appetite—Etoposide—urinary bladder cancer	0.00444	0.0051	CcSEcCtD
Benzatropine—Body temperature increased—Cisplatin—urinary bladder cancer	0.00441	0.00507	CcSEcCtD
Benzatropine—CYP2D6—urine—urinary bladder cancer	0.0044	0.133	CbGeAlD
Benzatropine—Constipation—Etoposide—urinary bladder cancer	0.00437	0.00502	CcSEcCtD
Benzatropine—Dysuria—Doxorubicin—urinary bladder cancer	0.00435	0.00501	CcSEcCtD
Benzatropine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00433	0.00498	CcSEcCtD
Benzatropine—Nausea—Thiotepa—urinary bladder cancer	0.00422	0.00486	CcSEcCtD
Benzatropine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00421	0.00484	CcSEcCtD
Benzatropine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00411	0.00472	CcSEcCtD
Benzatropine—Body temperature increased—Etoposide—urinary bladder cancer	0.00404	0.00464	CcSEcCtD
Benzatropine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00401	0.00461	CcSEcCtD
Benzatropine—Vomiting—Gemcitabine—urinary bladder cancer	0.0038	0.00437	CcSEcCtD
Benzatropine—Rash—Gemcitabine—urinary bladder cancer	0.00377	0.00434	CcSEcCtD
Benzatropine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00377	0.00433	CcSEcCtD
Benzatropine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00376	0.00433	CcSEcCtD
Benzatropine—Vomiting—Fluorouracil—urinary bladder cancer	0.00374	0.0043	CcSEcCtD
Benzatropine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00371	0.00427	CcSEcCtD
Benzatropine—Rash—Fluorouracil—urinary bladder cancer	0.00371	0.00426	CcSEcCtD
Benzatropine—Dermatitis—Fluorouracil—urinary bladder cancer	0.0037	0.00426	CcSEcCtD
Benzatropine—CHRM2—prostate gland—urinary bladder cancer	0.00359	0.108	CbGeAlD
Benzatropine—Nausea—Gemcitabine—urinary bladder cancer	0.00355	0.00408	CcSEcCtD
Benzatropine—Vomiting—Cisplatin—urinary bladder cancer	0.00354	0.00408	CcSEcCtD
Benzatropine—Vision blurred—Methotrexate—urinary bladder cancer	0.00353	0.00406	CcSEcCtD
Benzatropine—Rash—Cisplatin—urinary bladder cancer	0.00351	0.00404	CcSEcCtD
Benzatropine—Dermatitis—Cisplatin—urinary bladder cancer	0.00351	0.00404	CcSEcCtD
Benzatropine—Nausea—Fluorouracil—urinary bladder cancer	0.00349	0.00402	CcSEcCtD
Benzatropine—Tension—Epirubicin—urinary bladder cancer	0.00344	0.00396	CcSEcCtD
Benzatropine—Nervousness—Epirubicin—urinary bladder cancer	0.00341	0.00392	CcSEcCtD
Benzatropine—Nausea—Cisplatin—urinary bladder cancer	0.00331	0.00381	CcSEcCtD
Benzatropine—Vision blurred—Epirubicin—urinary bladder cancer	0.00331	0.0038	CcSEcCtD
Benzatropine—CHRM1—prostate gland—urinary bladder cancer	0.00327	0.0984	CbGeAlD
Benzatropine—Vomiting—Etoposide—urinary bladder cancer	0.00325	0.00373	CcSEcCtD
Benzatropine—Rash—Etoposide—urinary bladder cancer	0.00322	0.0037	CcSEcCtD
Benzatropine—Dermatitis—Etoposide—urinary bladder cancer	0.00322	0.0037	CcSEcCtD
Benzatropine—Tension—Doxorubicin—urinary bladder cancer	0.00318	0.00366	CcSEcCtD
Benzatropine—Nervousness—Doxorubicin—urinary bladder cancer	0.00315	0.00362	CcSEcCtD
Benzatropine—Confusional state—Methotrexate—urinary bladder cancer	0.00308	0.00355	CcSEcCtD
Benzatropine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00306	0.00352	CcSEcCtD
Benzatropine—Nausea—Etoposide—urinary bladder cancer	0.00303	0.00349	CcSEcCtD
Benzatropine—Dry mouth—Epirubicin—urinary bladder cancer	0.00292	0.00336	CcSEcCtD
Benzatropine—Confusional state—Epirubicin—urinary bladder cancer	0.00289	0.00332	CcSEcCtD
Benzatropine—Tachycardia—Epirubicin—urinary bladder cancer	0.00279	0.00321	CcSEcCtD
Benzatropine—Dry mouth—Doxorubicin—urinary bladder cancer	0.0027	0.00311	CcSEcCtD
Benzatropine—Confusional state—Doxorubicin—urinary bladder cancer	0.00267	0.00307	CcSEcCtD
Benzatropine—Decreased appetite—Methotrexate—urinary bladder cancer	0.00266	0.00306	CcSEcCtD
Benzatropine—Tachycardia—Doxorubicin—urinary bladder cancer	0.00258	0.00297	CcSEcCtD
Benzatropine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00252	0.0029	CcSEcCtD
Benzatropine—Decreased appetite—Epirubicin—urinary bladder cancer	0.00249	0.00286	CcSEcCtD
Benzatropine—Constipation—Epirubicin—urinary bladder cancer	0.00245	0.00281	CcSEcCtD
Benzatropine—Body temperature increased—Methotrexate—urinary bladder cancer	0.00242	0.00278	CcSEcCtD
Benzatropine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00236	0.00271	CcSEcCtD
Benzatropine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.0023	0.00265	CcSEcCtD
Benzatropine—Constipation—Doxorubicin—urinary bladder cancer	0.00226	0.0026	CcSEcCtD
Benzatropine—Body temperature increased—Epirubicin—urinary bladder cancer	0.00226	0.0026	CcSEcCtD
Benzatropine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00225	0.00259	CcSEcCtD
Benzatropine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00218	0.00251	CcSEcCtD
Benzatropine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00211	0.00243	CcSEcCtD
Benzatropine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00209	0.00241	CcSEcCtD
Benzatropine—HRH1—prostate gland—urinary bladder cancer	0.00208	0.0626	CbGeAlD
Benzatropine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00195	0.00224	CcSEcCtD
Benzatropine—Vomiting—Methotrexate—urinary bladder cancer	0.00194	0.00224	CcSEcCtD
Benzatropine—Rash—Methotrexate—urinary bladder cancer	0.00193	0.00222	CcSEcCtD
Benzatropine—Dermatitis—Methotrexate—urinary bladder cancer	0.00193	0.00222	CcSEcCtD
Benzatropine—Vomiting—Epirubicin—urinary bladder cancer	0.00182	0.00209	CcSEcCtD
Benzatropine—Nausea—Methotrexate—urinary bladder cancer	0.00182	0.00209	CcSEcCtD
Benzatropine—Rash—Epirubicin—urinary bladder cancer	0.0018	0.00208	CcSEcCtD
Benzatropine—Dermatitis—Epirubicin—urinary bladder cancer	0.0018	0.00207	CcSEcCtD
Benzatropine—CHRM1—female reproductive system—urinary bladder cancer	0.00178	0.0537	CbGeAlD
Benzatropine—Nausea—Epirubicin—urinary bladder cancer	0.0017	0.00196	CcSEcCtD
Benzatropine—Vomiting—Doxorubicin—urinary bladder cancer	0.00168	0.00194	CcSEcCtD
Benzatropine—Rash—Doxorubicin—urinary bladder cancer	0.00167	0.00192	CcSEcCtD
Benzatropine—Dermatitis—Doxorubicin—urinary bladder cancer	0.00167	0.00192	CcSEcCtD
Benzatropine—Nausea—Doxorubicin—urinary bladder cancer	0.00157	0.00181	CcSEcCtD
Benzatropine—HRH1—epithelium—urinary bladder cancer	0.00153	0.046	CbGeAlD
Benzatropine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00147	0.0443	CbGeAlD
Benzatropine—HRH1—urethra—urinary bladder cancer	0.00139	0.0419	CbGeAlD
Benzatropine—CYP2C19—vagina—urinary bladder cancer	0.00134	0.0404	CbGeAlD
Benzatropine—HRH1—female reproductive system—urinary bladder cancer	0.00113	0.0342	CbGeAlD
Benzatropine—CYP2D6—renal system—urinary bladder cancer	0.00108	0.0325	CbGeAlD
Benzatropine—HRH1—vagina—urinary bladder cancer	0.00103	0.0309	CbGeAlD
Benzatropine—CYP2D6—female reproductive system—urinary bladder cancer	0.000863	0.026	CbGeAlD
Benzatropine—CYP2C19—Biological oxidations—GSTO2—urinary bladder cancer	0.000664	0.00807	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—NAT1—urinary bladder cancer	0.000664	0.00807	CbGpPWpGaD
Benzatropine—HRH1—lymph node—urinary bladder cancer	0.000663	0.02	CbGeAlD
Benzatropine—CYP2C19—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000655	0.00796	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000644	0.00783	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000635	0.00773	CbGpPWpGaD
Benzatropine—SLC6A3—Alpha-synuclein signaling—SRC—urinary bladder cancer	0.000633	0.0077	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000611	0.00743	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000611	0.00743	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—UGT2B7—urinary bladder cancer	0.000607	0.00738	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000602	0.00732	CbGpPWpGaD
Benzatropine—CYP2C19—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000599	0.00728	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000558	0.00679	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000551	0.0067	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—CYP4B1—urinary bladder cancer	0.000547	0.00665	CbGpPWpGaD
Benzatropine—CYP2C19—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000539	0.00656	CbGpPWpGaD
Benzatropine—SLC6A3—NRF2 pathway—NQO1—urinary bladder cancer	0.000525	0.00638	CbGpPWpGaD
Benzatropine—SLC6A3—Monoamine Transport—TNF—urinary bladder cancer	0.000515	0.00627	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000503	0.00611	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000496	0.00603	CbGpPWpGaD
Benzatropine—SLC6A3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000476	0.00579	CbGpPWpGaD
Benzatropine—CYP2C19—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000462	0.00562	CbGpPWpGaD
Benzatropine—SLC6A3—NRF2 pathway—GSTP1—urinary bladder cancer	0.000438	0.00532	CbGpPWpGaD
Benzatropine—SLC6A3—NRF2 pathway—GSTM1—urinary bladder cancer	0.000402	0.00489	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000383	0.00466	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.000364	0.00442	CbGpPWpGaD
Benzatropine—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000359	0.00436	CbGpPWpGaD
Benzatropine—SLC6A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000344	0.00418	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.000335	0.00407	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00033	0.00401	CbGpPWpGaD
Benzatropine—HRH1—IL-4 Signaling Pathway—EP300—urinary bladder cancer	0.000329	0.00401	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000291	0.00354	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000282	0.00343	CbGpPWpGaD
Benzatropine—SLC6A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00028	0.00341	CbGpPWpGaD
Benzatropine—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000272	0.00331	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000267	0.00325	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000259	0.00315	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—urinary bladder cancer	0.000251	0.00306	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—urinary bladder cancer	0.000248	0.00302	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000248	0.00301	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000245	0.00298	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—FAS—urinary bladder cancer	0.000219	0.00267	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00021	0.00255	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000204	0.00248	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000195	0.00238	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—RHOA—urinary bladder cancer	0.000194	0.00236	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000193	0.00235	CbGpPWpGaD
Benzatropine—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000193	0.00234	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—RHOA—urinary bladder cancer	0.000191	0.00232	CbGpPWpGaD
Benzatropine—SLC6A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000189	0.0023	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.00018	0.00219	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.00018	0.00218	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000177	0.00216	CbGpPWpGaD
Benzatropine—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000177	0.00215	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000175	0.00213	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000165	0.00201	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000163	0.00198	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000162	0.00197	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000139	0.00169	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—urinary bladder cancer	0.000124	0.00151	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—urinary bladder cancer	0.000123	0.00149	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—PTEN—urinary bladder cancer	0.00012	0.00146	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.00012	0.00146	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—KRAS—urinary bladder cancer	0.000117	0.00143	CbGpPWpGaD
Benzatropine—CHRM2—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.000117	0.00142	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—urinary bladder cancer	0.000116	0.00141	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—EP300—urinary bladder cancer	0.000115	0.0014	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000114	0.00138	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000114	0.00138	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000113	0.00137	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000112	0.00136	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.00011	0.00134	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000106	0.00129	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000106	0.00129	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HDAC4—urinary bladder cancer	0.000105	0.00127	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000104	0.00127	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000104	0.00127	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	0.000104	0.00126	CbGpPWpGaD
Benzatropine—SLC6A3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.0001	0.00122	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	9.55e-05	0.00116	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	9.42e-05	0.00115	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	9.39e-05	0.00114	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	9.35e-05	0.00114	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	9.3e-05	0.00113	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	9.27e-05	0.00113	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	9.27e-05	0.00113	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—GLI1—urinary bladder cancer	8.9e-05	0.00108	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—GLI1—urinary bladder cancer	8.87e-05	0.00108	CbGpPWpGaD
Benzatropine—SLC6A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.87e-05	0.00108	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	8.83e-05	0.00107	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	8.78e-05	0.00107	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—GLI1—urinary bladder cancer	8.76e-05	0.00107	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	8.75e-05	0.00106	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	8.6e-05	0.00105	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	8.6e-05	0.00105	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—TP53—urinary bladder cancer	8.21e-05	0.000999	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	8.12e-05	0.000988	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	7.91e-05	0.000962	CbGpPWpGaD
Benzatropine—SLC6A3—Neuronal System—HRAS—urinary bladder cancer	7.69e-05	0.000935	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	7.47e-05	0.000908	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	7.44e-05	0.000905	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—CXCL8—urinary bladder cancer	7.17e-05	0.000872	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	7.15e-05	0.000869	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—CXCL8—urinary bladder cancer	7.06e-05	0.000858	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.9e-05	0.000839	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	6.88e-05	0.000836	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.61e-05	0.000803	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	6.33e-05	0.000769	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	6.22e-05	0.000756	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RBX1—urinary bladder cancer	6.1e-05	0.000742	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RBX1—urinary bladder cancer	6.08e-05	0.00074	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RBX1—urinary bladder cancer	6e-05	0.00073	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TSC1—urinary bladder cancer	5.74e-05	0.000698	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.72e-05	0.000696	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TSC1—urinary bladder cancer	5.72e-05	0.000696	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TSC1—urinary bladder cancer	5.65e-05	0.000687	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JAG1—urinary bladder cancer	5.46e-05	0.000664	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JAG1—urinary bladder cancer	5.44e-05	0.000662	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JAG1—urinary bladder cancer	5.37e-05	0.000654	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	5.37e-05	0.000653	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.97e-05	0.000605	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.97e-05	0.000605	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.94e-05	0.000601	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.94e-05	0.000601	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.82e-05	0.000587	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.75e-05	0.000578	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—RHOA—urinary bladder cancer	4.62e-05	0.000562	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	4.6e-05	0.00056	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.57e-05	0.000556	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.57e-05	0.000556	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—RHOA—urinary bladder cancer	4.54e-05	0.000553	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.44e-05	0.000539	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—S100B—urinary bladder cancer	4.42e-05	0.000538	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—S100B—urinary bladder cancer	4.41e-05	0.000536	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—S100B—urinary bladder cancer	4.35e-05	0.000529	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—RHOA—urinary bladder cancer	4.19e-05	0.00051	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—RHOA—urinary bladder cancer	4.18e-05	0.000508	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—RHOA—urinary bladder cancer	4.13e-05	0.000502	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.05e-05	0.000493	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.04e-05	0.000491	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	4.01e-05	0.000487	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.99e-05	0.000485	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	3.98e-05	0.000484	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NCOR1—urinary bladder cancer	3.96e-05	0.000482	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NCOR1—urinary bladder cancer	3.91e-05	0.000476	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.89e-05	0.000473	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	3.87e-05	0.000471	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—IL2—urinary bladder cancer	3.86e-05	0.00047	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—IL2—urinary bladder cancer	3.81e-05	0.000464	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.69e-05	0.000448	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	3.68e-05	0.000448	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	3.67e-05	0.000446	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—CXCL8—urinary bladder cancer	3.62e-05	0.00044	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	3.52e-05	0.000428	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL2—urinary bladder cancer	3.51e-05	0.000426	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TERT—urinary bladder cancer	3.5e-05	0.000426	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TERT—urinary bladder cancer	3.49e-05	0.000425	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL2—urinary bladder cancer	3.46e-05	0.000421	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TERT—urinary bladder cancer	3.45e-05	0.000419	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.39e-05	0.000412	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.34e-05	0.000407	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.23e-05	0.000393	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	3.22e-05	0.000391	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGFR3—urinary bladder cancer	3.21e-05	0.00039	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGFR3—urinary bladder cancer	3.16e-05	0.000385	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	3.12e-05	0.00038	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ESR1—urinary bladder cancer	3.11e-05	0.000379	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.11e-05	0.000378	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.07e-05	0.000374	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ESR1—urinary bladder cancer	3.07e-05	0.000374	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.07e-05	0.000374	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.07e-05	0.000374	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.94e-05	0.000358	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.89e-05	0.000351	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.86e-05	0.000348	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.83e-05	0.000344	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.83e-05	0.000344	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	2.74e-05	0.000333	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CREBBP—urinary bladder cancer	2.73e-05	0.000332	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.72e-05	0.00033	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.71e-05	0.000329	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	2.7e-05	0.000329	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IGF1—urinary bladder cancer	2.7e-05	0.000328	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CREBBP—urinary bladder cancer	2.69e-05	0.000328	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	2.69e-05	0.000327	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—EGFR—urinary bladder cancer	2.68e-05	0.000326	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IGF1—urinary bladder cancer	2.66e-05	0.000324	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.66e-05	0.000323	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—EGFR—urinary bladder cancer	2.65e-05	0.000322	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	2.54e-05	0.000309	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—KRAS—urinary bladder cancer	2.53e-05	0.000308	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—KRAS—urinary bladder cancer	2.5e-05	0.000304	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.5e-05	0.000304	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	2.48e-05	0.000301	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RHOA—urinary bladder cancer	2.47e-05	0.0003	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	2.44e-05	0.000296	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	2.29e-05	0.000279	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	2.29e-05	0.000278	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	2.26e-05	0.000274	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.2e-05	0.000268	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	2.17e-05	0.000264	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	2.17e-05	0.000264	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	2.16e-05	0.000263	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	2.15e-05	0.000262	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	2.14e-05	0.00026	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	2.13e-05	0.000259	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.11e-05	0.000257	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	2.08e-05	0.000253	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	2.07e-05	0.000252	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	2.04e-05	0.000249	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	2.03e-05	0.000246	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.02e-05	0.000246	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	2.02e-05	0.000246	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	1.99e-05	0.000242	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	1.97e-05	0.000239	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	1.96e-05	0.000238	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.96e-05	0.000238	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	1.96e-05	0.000238	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.95e-05	0.000238	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	1.95e-05	0.000237	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.95e-05	0.000237	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	1.94e-05	0.000235	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.93e-05	0.000235	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	1.92e-05	0.000234	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	1.86e-05	0.000227	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	1.86e-05	0.000226	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	1.83e-05	0.000223	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	1.81e-05	0.000221	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	1.81e-05	0.00022	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	1.78e-05	0.000217	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.73e-05	0.000211	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	1.62e-05	0.000198	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	1.62e-05	0.000197	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	1.6e-05	0.000194	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.59e-05	0.000194	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	1.59e-05	0.000193	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	1.58e-05	0.000193	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	1.56e-05	0.00019	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.51e-05	0.000184	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	1.5e-05	0.000183	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	1.5e-05	0.000182	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	1.48e-05	0.00018	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.44e-05	0.000175	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.39e-05	0.000169	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	1.33e-05	0.000162	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	1.33e-05	0.000162	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.32e-05	0.000161	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	1.31e-05	0.00016	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	1.28e-05	0.000155	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	1.27e-05	0.000155	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	1.26e-05	0.000153	CbGpPWpGaD
